laboratorio de hemoderivados - unc

What laboratorio de hemoderivados - unc does

Laboratorio de Hemoderivados - UNC is a public, non-profit pharmaceutical laboratory operated by the Universidad Nacional de Córdoba (UNC), founded in 1964 under President Arturo Illia to guarantee Argentine access to essential medicines. It operates as the only functional plasma fractionation plant in Latin America completing the full cycle from raw plasma to finished product, organized into three product divisions: UNC Hemoderivados (plasma-derived medicines including immunoglobulins, albumin, antithrombin III, prothrombin complex, Factor VIII, and tetanus/Rho immunoglobulins), UNC Biotecnia (human tissue processing for traumatology, ophthalmology, and dentistry), and UNC Fármacos (small-volume injectable medications for hospital use).

The laboratory's underlying technology centers on plasma fractionation, pharmaceutical manufacturing, and human tissue processing, supported by molecular biology techniques for quality control. It holds two patents, including a 2022 synthetic RNA molecule patent developed jointly with UNC-CONICET for viral RNA detection. Plasma supply is secured through a national donation network partnering with blood banks and hemotherapy centers across Argentina (including Mendoza, Hospital de Clínicas UBA, and Hemocentro Buenos Aires).

The business model is non-profit and government-aligned: products are supplied primarily to Argentina's public health system and exported to neighboring South American countries, with prices regulated to ensure access rather than maximize margin. Go-to-market is sales-led for institutional public-sector procurement, complemented by community-led plasma donation campaigns and healthcare professional training. Revenue is not publicly disclosed, and the entity is wholly owned by UNC, with no venture capital or private equity involvement. The workforce is 101-250 employees, with a Director Ejecutivo (Héctor Gabriel Tavella) and senior management overseeing operations from Córdoba and a Buenos Aires administrative office.

Name

laboratorio de hemoderivados - unc

Legal name

Laboratorio de Hemoderivados de la Universidad Nacional de Córdoba

Website

https://unc-hemoderivados.com.ar

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

101–250 employees

Short description

Laboratorio de Hemoderivados is a public non-profit pharmaceutical laboratory operated by Universidad Nacional de Córdoba, producing plasma-derived medicines, human tissues, and hospital injectables for Argentina's public health system and regional markets.

Ownership category

akta.pro rank

Product category

Plasma-derived pharmaceuticals and biopharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Hematology Specialty Pharmaceuticals (Non-malignant) (HLAIACAI)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Plasma-derived medicines
• Human tissue processing
• Injectable pharmaceuticals
• Plasma fractionation
• Public pharmaceutical laboratory

Headquarters

HQ city

Córdoba

HQ country

Argentina

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Plasma-derived medicines sales: Production and sale of essential medicines derived from human plasma including immunoglobulins, albumin, clotting factors, and antitoxins. Supplies Argentina's public health system and neighboring countries. As a public non-profit laboratory, prices are regulated to ensure access to essential medicines.
2. Pharmaceutical injectables: Production of small-volume injectable medicines for hospital use, with strong presence in Argentina's public health system.
3. Human tissue products: Processing and distribution of human-origin tissue products for medical specialties including orthopedics, ophthalmology, and dentistry.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Laboratorio de Hemoderivados - UNC manufactures and distributes essential medicines across three product divisions: (1) UNC Hemoderivados produces plasma-derived medications including immunoglobulins, human serum albumin, coagulation factors (Factor VIII, prothrombin complex, antithrombin III), and antitoxins; (2) UNC Biotecnia processes human-origin tissues for therapeutic use in traumatology, ophthalmology, and dentistry; (3) UNC Fármacos manufactures small-volume injectable pharmaceuticals for hospital use including electrolytes, anesthetics, diuretics, and antiemetics. As a public non-profit laboratory, it operates without profit motives to ensure access to essential medicines.

Product overview

Laboratorio de Hemoderivados - UNC is a public pharmaceutical laboratory organized into three distinct product divisions under the UNC brand. UNC Hemoderivados produces plasma-derived medications including immunoglobulins (Inmunoglobulina G Endovenosa, Gammasub, Gammaglobulina T), albumin (Albúmina Sérica Humana), coagulation factors (Factor VIII Antihemofílico, Complejo Protrombínico, Antitrombina III), and tetanus/Rho immunoglobulins for immunological, neurological, and coagulation disorder treatment. UNC Biotecnia processes human tissues including bone matrix (Matriz Ósea) and other human tissues (Tejido Humano) for therapeutic use in traumatology, ophthalmology, and dentistry. UNC Fármacos manufactures small-volume injectable medications for hospital use including electrolytes (Cloruro de Sodio, Cloruro de Potasio), distilled water, diuretics (Furosemida), anesthetics (Lidocaína), and antiemetics (Metoclopramida). The laboratory is the only operational plant in Latin America completing the full plasma fractionation cycle from plasma to finished product.

Differentiator

Problem solved

Functional benefit

Brands

• UNC Hemoderivados: Plasma-derived medications for prevention and treatment of immunological, neurological diseases, and coagulation disorders.
• UNC Biotecnia
• UNC Fármacos

Products and services

• Inmunoglobulina G Endovenosa UNC Intravenous immunoglobulin G medication for treatment of immunological and neurological conditions, produced via patented process.
• Gammasub UNC Plasma-derived subcutaneous immunoglobulin product for immunological disorders.
• Albúmina Sérica Humana UNC Human serum albumin for clinical use in treating various conditions.
• Antitrombina III UNC Pasteurizada Pasteurized antithrombin III for coagulation disorder treatment.
• Complejo Protrombínico UNC Prothrombin complex concentrate for treatment of coagulation disorders.
• Factor VIII Antihemofílico UNC Antihemophilic factor VIII for treatment of hemophilia A.
• Gamma Antitetánica UNC Plus Anti-tetanus immunoglobulin for tetanus prevention and treatment.
• Gamma Anti-Rho UNC Anti-Rho immunoglobulin for prevention of Rh incompatibility.
• Gammaglobulina T T-globulin product acting on the immune system for patients requiring passive immunity support.
• Matriz Ósea UNC Bone matrix product for therapeutic use in traumatology.
• Tejido Humano UNC Processed human tissue for therapeutic use in various medical specialties including ophthalmology and dentistry.
• Agua Bidestilada UNC Bidistilled water for pharmaceutical use.
• Cloruro de Potasio UNC Potassium chloride injectable solution for hospital use.
• Cloruro de Sodio UNC Sodium chloride injectable solution for hospital use.
• Dexametasona UNC Dexamethasone injectable medication for hospital use.
• Difenhidramina UNC Diphenhydramine injectable medication for hospital use.
• Furosemida UNC Furosemide injectable diuretic for hospital use.
• Lidocaína UNC Lidocaine injectable anesthetic for hospital use.
• Metoclopramida UNC Metoclopramide injectable medication for gastrointestinal use.
• Ranitidina UNC Ranitidine injectable medication for hospital use.
• Solución Fisiológica UNC Physiological saline solution for pharmaceutical and hospital use.

Quantifiable outcome

• Only plant in Latin America with complete plasma fractionation cycle
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

23 partnerships are on record, tiered core and minor.

• Centro Regional de Hemoterapia de MendozacoreStrategic or Co-development PartnerMendoza blood bank joined the plasma donation network, strengthening the regional collection effort and expanding opportunities for voluntary plasma donation in the Cuyo region.
• Centro de Hemoterapia del Hospital de Clínicas de la UBAcoreStrategic or Co-development PartnerBuenos Aires blood bank incorporated into plasma donation network, expanding collection capacity in the capital district.
• Fundación Hemocentro Buenos AirescoreStrategic or Co-development PartnerBuenos Aires foundation joins plasma donation campaign, contributing to national plasma collection efforts.
• Pacto Global ArgentinacoreStrategic or Co-development PartnerActive board member of Pact Global Argentina network, contributing to UN Sustainable Development Goals. Continues as titular member elected for 2024-2026 period. Hosted 20th anniversary celebration in Córdoba.
• Agencia Nacional de Laboratorios Públicos (ANLAP)coreStrategic or Co-development PartnerMember of National Agency of Public Laboratories, contributing to public pharmaceutical production policy in Argentina.
• Cámara Industrial de Laboratorios Farmacéuticos Argentinos (CILFA)minorOthersMember of the Industrial Chamber of Argentine Pharmaceutical Laboratories, representing the industry and contributing to sector policy discussions.
• Cámara de Industrias de la Salud de la Provincia de Córdoba (CAISAL)minorOthersMember of Health Industries Chamber of Córdoba Province, contributing to regional health industry development.
• Asociación Argentina de Farmacia y Bioquímica Industrial (SAFYBI)minorOthersMember of Argentine Association of Industrial Pharmacy and Biochemistry.
• Cámara de Comercio Exterior de Córdoba (CACEC)minorOthersMember of Foreign Trade Chamber of Córdoba.
• Instituto Argentino de Responsabilidad Social Empresaria (IARSE)minorOthersMember of Argentine Institute of Corporate Social Responsibility.
• Fundación Banco Central de SangrecoreStrategic or Co-development PartnerBlood bank foundation joined plasma donation campaign, expanding collection network.
• Clúster de Biotecnología de CórdobacoreStrategic or Co-development PartnerJoined biotechnology cluster with objective of contributing to new strategies and actions for sector growth.
• Universidad Nacional de CórdobacoreStrategic or Co-development PartnerParent institution. Laboratory operates within UNC ecosystem, receiving institutional support and contributing to academic mission.
• Centro de Investigaciones en Bioquímica Clínica e Inmunología (UNC-CONICET)coreStrategic or Co-development PartnerCollaborative research partnership leading to new patent for synthetic RNA molecule control. Joint work between Development of Products and Processes area and the research center.
• Centro de Información de Medicamentos de la Facultad de Ciencias Químicas (UNC)coreStrategic or Co-development PartnerCollaboration on pharmacovigilance training and patient safety education activities.
• DaspuminorStrategic or Co-development PartnerPharmacovigilance program partnership with university health insurance, conducting continuous study on Gammaglobulina T usage.
• Hospital GarrahancoreStrategic or Co-development PartnerHealthcare institution participating in immunoglobin G training sessions organized by the laboratory.
• Fundación Luz Guillain-BarréminorStrategic or Co-development PartnerPartner in training session on Guillain-Barré syndrome for healthcare professionals.
• Sociedad Neurológica ArgentinaminorStrategic or Co-development PartnerProfessional society providing endorsement for Guillain-Barré training session.
• Hospital de Niños de CórdobacoreStrategic or Co-development PartnerPartner in hemophilia workshop and autoinfusion training for patients.
• Filial Córdoba de la Fundación de la HemofiliacoreStrategic or Co-development PartnerLong-standing partnership organizing hemophilia awareness and treatment education events.
• Instituto Nacional Central Único Coordinador de Ablación e Implante (INCUCAI)coreStrategic or Co-development PartnerUpcoming SCOW UNC production to primarily supply INCUCAI for organ preservation, covering estimated 6,000 liters annual national demand.
• Facultad de Artes (UNC)minorStrategic or Co-development PartnerArt installations at laboratory premises representing institutional essence and values from artistic perspective.

Scale indicators6 records

Recent moves6 records

Expansion highlights12 records

Direct peers

• CSL Behring: Major plasma fractionator and specialty biotherapeutics manufacturer with a broad portfolio of immunoglobulins, coagulation factors, and albumin products. Highly comparable to UNC Hemoderivados across plasma-derived therapeutic categories.
• Biotest AG: Specialty plasma protein therapeutics company focused on immunoglobulin, coagulation, and albumin products. Comparable scale and product overlap in plasma fractionation and hematology specialty pharmaceuticals.
• Takeda Pharmaceutical (Plasma-Derived Therapies): Through the Shire acquisition, Takeda operates one of the largest plasma-derived therapy franchises globally, including immunoglobulin and hematology products. Comparable therapeutic categories and scale of plasma fractionation operations.
• Instituto Butantan: Brazilian public health institute producing vaccines and biopharmaceuticals under a state-government mission. Comparable non-profit, public-sector pharmaceutical production model with focus on access to essential medicines in the Latin American region.
• Grifols: Global leader in plasma-derived medicines, producing immunoglobulins, albumin, clotting factors, and specialty plasma products. Direct peer given UNC's full-cycle plasma fractionation business and overlapping therapeutic areas across hematology, immunology, and critical care.
• Sanquin: Dutch blood supply foundation responsible for blood collection and plasma fractionation in the Netherlands. Comparable mission-aligned model combining voluntary donor-based plasma supply with fractionation into plasma-derived medicines, structurally similar to UNC's plasma donation-to-product cycle.
• Kedrion Biopharma: Italy-based plasma fractionator producing immunoglobulins, albumin, and coagulation factors for global markets, including Latin America. Directly comparable business model with focus on national plasma self-sufficiency similar to UNC's mission.
• Octapharma: Privately-held global manufacturer of plasma-derived and recombinant products for hematology, immunotherapy, and critical care. Direct competitor in plasma fractionation and overlapping product categories including coagulation factors and immunoglobulins.
• LFB (Laboratoire Français du Fractionnement et des Biotechnologies): French public-interest plasma fractionator producing plasma-derived medicines for the French national health system. Highly comparable mission-aligned model combining non-profit/government-linked ownership with full-cycle plasma fractionation, similar to UNC.
• Green Cross (GC Biopharma): Korean plasma-derived products manufacturer producing immunoglobulins, albumin, and coagulation factors. Comparable plasma fractionation focus with regional self-sufficiency mission analogous to UNC's Argentine public-health mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/laboratoriounc
• Facebookfacebook.com/unchemoderivados
• Instagraminstagram.com/laboratoriounc
• LinkedInlinkedin.com/company/laboratorio-de-hemoderivados---unc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about laboratorio de hemoderivados - unc